Division of Gastroenterology and HepatologyDepartment of MedicineIndiana University School of MedicineIndianapolisIN.
Division of Gastroenterology and HepatologyDepartment of MedicineUniversity of Pennsylvania Perelman School of MedicinePhiladelphiaPA.
Liver Transpl. 2021 Jun;27(6):900-912. doi: 10.1002/lt.25996.
Liver transplantation (LT) is a life-saving therapy; therefore, equitable distribution of this scarce resource is of paramount importance. We searched contemporary literature on racial, gender, and socioeconomic disparities across the LT care cascade in referral, waitlist practices, allocation, and post-LT care. We subsequently identified gaps in the literature and future research priorities. Studies found that racial and ethnic minorities (Black and Hispanic patients) have lower rates of LT referral, more advanced liver disease and hepatocellular carcinoma at diagnosis, and are less likely to undergo living donor LT (LDLT). Gender-based disparities were observed in waitlist mortality and LT allocation. Women have lower LT rates after waitlisting, with size mismatch accounting for much of the disparity. Medicaid insurance has been associated with higher rates of chronic liver disease and poor waitlist outcomes. After LT, some studies found lower overall survival among Black compared with White recipients. Studies have also shown lower literacy and limited educational attainment were associated with increased posttransplant complications and lower use of digital technology. However, there are notable gaps in the literature on disparities in LT. Detailed population-based estimates of the advanced liver disease burden and LT referral and evaluation practices, including for LDLT, are lacking. Similarly, little is known about LT disparities worldwide. Evidence-based strategies to improve access to care and reduce disparities have not been comprehensively identified. Prospective registries and alternative "real-world" databases can provide more detailed information on disease burden and clinical practices. Modeling and simulation studies can identify ways to reduce gender disparities attributed to size or inaccurate estimation of renal function. Mixed-methods studies and clinical trials should be conducted to reduce care disparities across the transplant continuum.
肝移植 (LT) 是一种救命疗法;因此,公平分配这种稀缺资源至关重要。我们搜索了当代文献,以了解在转诊、等待名单实践、分配和 LT 后护理方面,LT 护理级联中存在的种族、性别和社会经济差异。随后,我们确定了文献中的差距和未来的研究重点。研究发现,少数族裔和少数民族(黑人和西班牙裔患者)接受 LT 转诊的比例较低,诊断时肝脏疾病和肝细胞癌更为严重,并且不太可能接受活体供肝 LT(LDLT)。在等待名单死亡率和 LT 分配方面存在性别差异。女性在等待名单上的死亡率较低,而大小不匹配是造成这种差异的主要原因。医疗补助保险与慢性肝病发病率较高和等待名单结果不佳有关。LT 后,一些研究发现黑人患者的总体生存率低于白人患者。研究还表明,文化程度较低和教育程度有限与移植后并发症增加和数字技术使用减少有关。然而,关于 LT 差异的文献存在明显差距。缺乏详细的基于人群的先进肝病负担和 LT 转诊和评估实践的估计,包括 LDLT。同样,关于全球 LT 差异的信息也知之甚少。尚未全面确定改善护理机会和减少差异的循证策略。前瞻性登记处和替代“真实世界”数据库可以提供有关疾病负担和临床实践的更详细信息。建模和模拟研究可以确定如何减少因大小或肾功能估计不准确而导致的性别差异。应进行混合方法研究和临床试验,以减少整个移植过程中的护理差异。